{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T16:43:47Z","timestamp":1776012227306,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T00:00:00Z","timestamp":1580947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T00:00:00Z","timestamp":1580947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA83237"],"award-info":[{"award-number":["CA83237"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA159871"],"award-info":[{"award-number":["CA159871"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["MD"],"award-info":[{"award-number":["MD"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM055036"],"award-info":[{"award-number":["GM055036"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Maryland Stem Cell Foundation MSCRFI-1638"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Despite recent advances in melanoma treatment, metastasis and resistance to therapy remain serious clinical challenges. NME1 is a metastasis suppressor, a class of proteins which inhibits metastatic spread of cancer cells without impact on growth of the primary tumor. We have identified a rare subpopulation of cells with markedly reduced expression of NME1 (NME1<jats:sup><jats:italic>LOW<\/jats:italic><\/jats:sup>) in human melanoma cell lines. To enable isolation of viable NME1<jats:sup><jats:italic>LOW<\/jats:italic><\/jats:sup> cells for phenotypic analysis by fluorescence-activated cell sorting (FACS), a CRISPR-Cas9-mediated approach was used to attach an EGFP coding module to the C-terminus of the endogenous NME1 gene in melanoma cell lines. NME1<jats:sup><jats:italic>LOW<\/jats:italic><\/jats:sup> cells displayed enhanced collective invasion <jats:italic>in vitro<\/jats:italic> when implanted as 3D aggregates in Matrigel. NME1<jats:sup><jats:italic>LOW<\/jats:italic><\/jats:sup> cells were also highly metastatic to lung and liver when xenografted subcutaneously in immune-deficient NSG mice. RNA-seq analysis revealed that NME1<jats:sup><jats:italic>LOW<\/jats:italic><\/jats:sup> cells express elevated levels of genes associated with tumor aggressiveness, as well as with morphogenesis of tissues of neural crest-like origin (melanocytes and neurons, bone and heart tissues; GO: 0009653). The highly malignant NME1<jats:sup><jats:italic>LOW<\/jats:italic><\/jats:sup> variant of melanoma cells has potential to provide novel therapeutic targets and molecular markers for improved clinical management of patients with advanced melanoma.<\/jats:p>","DOI":"10.1038\/s41598-020-58996-3","type":"journal-article","created":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T11:04:48Z","timestamp":1580987088000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 is highly metastatic in vivo"],"prefix":"10.1038","volume":"10","author":[{"given":"Devin","family":"Snyder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2761-8970","authenticated-orcid":false,"given":"David M.","family":"Kaetzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,6]]},"reference":[{"key":"58996_CR1","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.1158\/0008-5472.CAN-16-1330","volume":"76","author":"IJ Fidler","year":"2016","unstructured":"Fidler, I. J. Commentary on \u201cTumor Heterogeneity and the Biology of Cancer Invasion and Metastasis\u201d. Cancer Res. 76, 3441\u20133442, https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-1330 (2016).","journal-title":"Cancer Res."},{"key":"58996_CR2","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.tranon.2017.09.007","volume":"10","author":"TM Grzywa","year":"2017","unstructured":"Grzywa, T. M., Paskal, W. & W\u0142odarski, P. K. Intratumor and Intertumor Heterogeneity in Melanoma. Transl. Oncol. 10, 956\u2013975, https:\/\/doi.org\/10.1016\/j.tranon.2017.09.007 (2017).","journal-title":"Transl. Oncol."},{"issue":"12","key":"58996_CR3","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.3390\/ijms17122142","volume":"17","author":"Marta Tellez-Gabriel","year":"2016","unstructured":"Tellez-Gabriel, M., Ory, B., Lamoureux, F., Heymann, M. F. & Heymann, D. Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis. Int J Mol Sci 17, https:\/\/doi.org\/10.3390\/ijms17122142 (2016).","journal-title":"International Journal of Molecular Sciences"},{"key":"58996_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2147\/ITT.S134842","volume":"7","author":"B Domingues","year":"2018","unstructured":"Domingues, B., Lopes, J. M., Soares, P. & P\u00f3pulo, H. Melanoma treatment in review. Immunotargets Ther. 7, 35\u201349, https:\/\/doi.org\/10.2147\/ITT.S134842 (2018).","journal-title":"Immunotargets Ther."},{"key":"58996_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bbcan.2009.11.002","volume":"1805","author":"A Marusyk","year":"2010","unstructured":"Marusyk, A. & Polyak, K. Tumor heterogeneity: causes and consequences. Biochim. Biophys. Acta 1805, 105\u2013117, https:\/\/doi.org\/10.1016\/j.bbcan.2009.11.002 (2010).","journal-title":"Biochim. Biophys. Acta"},{"key":"58996_CR6","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.cell.2009.08.017","volume":"138","author":"M Shackleton","year":"2009","unstructured":"Shackleton, M., Quintana, E., Fearon, E. R. & Morrison, S. J. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 138, 822\u2013829, https:\/\/doi.org\/10.1016\/j.cell.2009.08.017 (2009).","journal-title":"Cell"},{"key":"58996_CR7","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1126\/science.aat7171","volume":"361","author":"JG Reiter","year":"2018","unstructured":"Reiter, J. G. et al. Minimal functional driver gene heterogeneity among untreated metastases. Sci. 361, 1033\u20131037, https:\/\/doi.org\/10.1126\/science.aat7171 (2018).","journal-title":"Sci."},{"key":"58996_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.semcancer.2010.12.008","volume":"21","author":"S Thiolloy","year":"2011","unstructured":"Thiolloy, S. & Rinker-Schaeffer, C. W. Thinking outside the box: using metastasis suppressors as molecular tools. Semin. Cancer Biol. 21, 89\u201398, https:\/\/doi.org\/10.1016\/j.semcancer.2010.12.008 (2011).","journal-title":"Semin. Cancer Biol."},{"key":"58996_CR9","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/jnci\/80.3.200","volume":"80","author":"PS Steeg","year":"1988","unstructured":"Steeg, P. S. et al. Evidence for a novel gene associated with low tumor metastatic potential. J. Natl Cancer Inst. 80, 200\u2013204 (1988).","journal-title":"J. Natl Cancer Inst."},{"key":"58996_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00210-014-1010-4","volume":"388","author":"DM Kaetzel","year":"2015","unstructured":"Kaetzel, D. M. et al. Dual functions of NME1 in suppression of cell motility and enhancement of genomic stability in melanoma. Naunyn-Schmiedebergs Arch. Pharmacology 388, 199\u2013206, https:\/\/doi.org\/10.1007\/s00210-014-1010-4 (2015).","journal-title":"Naunyn-Schmiedebergs Arch. Pharmacology"},{"key":"58996_CR11","first-page":"175","volume":"11","author":"JR McCorkle","year":"2014","unstructured":"McCorkle, J. R. et al. The metastasis suppressor NME1 regulates expression of genes linked to metastasis and patient outcome in melanoma and breast carcinoma. Cancer Genomics Proteom. 11, 175\u2013194 (2014).","journal-title":"Cancer Genomics Proteom."},{"key":"58996_CR12","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/exd.12697","volume":"24","author":"M Novak","year":"2015","unstructured":"Novak, M. et al. Metastasis suppressor NME1 regulates melanoma cell morphology, self-adhesion and motility via induction of fibronectin expression. Exp. Dermatol. 24, 455\u2013461, https:\/\/doi.org\/10.1111\/exd.12697 (2015).","journal-title":"Exp. Dermatol."},{"key":"58996_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1158\/0008-5472.CAN-11-1795","volume":"72","author":"SG Jarrett","year":"2012","unstructured":"Jarrett, S. G. et al. Metastasis suppressor NM23-H1 promotes repair of UV-induced DNA damage and suppresses UV-induced melanomagenesis. Cancer Res. 72, 133\u2013143, https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-1795 (2012).","journal-title":"Cancer Res."},{"key":"58996_CR14","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1023\/A:1005597231776","volume":"32","author":"MT Hartsough","year":"2000","unstructured":"Hartsough, M. T. & Steeg, P. S. Nm23\/nucleoside diphosphate kinase in human cancers. J. Bioenerg. Biomembr. 32, 301\u2013308 (2000).","journal-title":"J. Bioenerg. Biomembr."},{"key":"58996_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48882-y","volume":"9","author":"P Ozretic","year":"2019","unstructured":"Ozretic, P. et al. Expression profiles of p53\/p73, NME and GLI families in metastatic melanoma tissue and cell lines. Sci. Rep. 9, 12470, https:\/\/doi.org\/10.1038\/s41598-019-48882-y (2019).","journal-title":"Sci. Rep."},{"key":"58996_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/bjc.1996.323","volume":"74","author":"DJ Easty","year":"1996","unstructured":"Easty, D. J. et al. Expression of NM23 in human melanoma progression and metastasis. Br. J. Cancer 74, 109\u2013114, https:\/\/doi.org\/10.1038\/bjc.1996.323 (1996).","journal-title":"Br. J. Cancer"},{"key":"58996_CR17","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1158\/1541-7786.MCR-18-0019","volume":"17","author":"Y Wang","year":"2019","unstructured":"Wang, Y. et al. NME1 Drives Expansion of Melanoma Cells with Enhanced Tumor Growth and Metastatic Properties. Mol. Cancer Res. 17, 1665\u20131674, https:\/\/doi.org\/10.1158\/1541-7786.MCR-18-0019 (2019).","journal-title":"Mol. Cancer Res."},{"key":"58996_CR18","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.cell.2010.04.020","volume":"141","author":"A Roesch","year":"2010","unstructured":"Roesch, A. et al. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 141, 583\u2013594, https:\/\/doi.org\/10.1016\/j.cell.2010.04.020 (2010).","journal-title":"Cell"},{"key":"58996_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Sci. 352, 189\u2013196, https:\/\/doi.org\/10.1126\/science.aad0501 (2016).","journal-title":"Sci."},{"key":"58996_CR20","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/onc.2017.341","volume":"37","author":"M Perego","year":"2018","unstructured":"Perego, M. et al. A slow-cycling subpopulation of melanoma cells with highly invasive properties. Oncogene 37, 302\u2013312, https:\/\/doi.org\/10.1038\/onc.2017.341 (2018).","journal-title":"Oncogene"},{"key":"58996_CR21","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1091\/mbc.E17-03-0209","volume":"28","author":"B Roberts","year":"2017","unstructured":"Roberts, B. et al. Systematic gene tagging using CRISPR\/Cas9 in human stem cells to illuminate cell organization. Mol. Biol. Cell 28, 2854\u20132874, https:\/\/doi.org\/10.1091\/mbc.E17-03-0209 (2017).","journal-title":"Mol. Biol. Cell"},{"key":"58996_CR22","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","volume":"154","author":"FA Ran","year":"2013","unstructured":"Ran, F. A. et al. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154, 1380\u20131389, https:\/\/doi.org\/10.1016\/j.cell.2013.08.021 (2013).","journal-title":"Cell"},{"key":"58996_CR23","doi-asserted-by":"publisher","first-page":"W171","DOI":"10.1093\/nar\/gkz365","volume":"47","author":"K Labun","year":"2019","unstructured":"Labun, K. et al. CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing. Nucleic Acids Res. 47, W171\u2013W174, https:\/\/doi.org\/10.1093\/nar\/gkz365 (2019).","journal-title":"Nucleic Acids Res."},{"key":"58996_CR24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.yexcr.2004.04.018","volume":"298","author":"MH Bosnar","year":"2004","unstructured":"Bosnar, M. H. et al. Subcellular localization of A and B Nm23\/NDPK subunits. Exp. Cell Res. 298, 275\u2013284, https:\/\/doi.org\/10.1016\/j.yexcr.2004.04.018 (2004).","journal-title":"Exp. Cell Res."},{"key":"58996_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1471-2148-11-87","volume":"11","author":"D Perina","year":"2011","unstructured":"Perina, D. et al. Sponge non-metastatic Group I Nme gene\/protein - structure and function is conserved from sponges to humans. BMC Evol. Biol. 11, 87, https:\/\/doi.org\/10.1186\/1471-2148-11-87 (2011).","journal-title":"BMC Evol. Biol."},{"key":"58996_CR26","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/ijc.25307","volume":"128","author":"Q Zhang","year":"2011","unstructured":"Zhang, Q., McCorkle, J. R., Novak, M., Yang, M. & Kaetzel, D. M. Metastasis suppressor function of NM23-H1 requires its 3\u2032;-5\u2032 exonuclease activity. Int. J. Cancer 128, 40\u201350 (2011).","journal-title":"Int. J. Cancer"},{"key":"58996_CR27","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1093\/jnci\/56.6.1279","volume":"56","author":"AF Steuer","year":"1976","unstructured":"Steuer, A. F. & Ting, R. C. Formation of larger cell aggregates by transformed cells: an in vitro index of cell transformation. J. Natl Cancer Inst. 56, 1279\u20131280, https:\/\/doi.org\/10.1093\/jnci\/56.6.1279 (1976).","journal-title":"J. Natl Cancer Inst."},{"key":"58996_CR28","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/ncb2548","volume":"14","author":"P Friedl","year":"2012","unstructured":"Friedl, P., Locker, J., Sahai, E. & Segall, J. E. Classifying collective cancer cell invasion. Nat. Cell Biol. 14, 777\u2013783, https:\/\/doi.org\/10.1038\/ncb2548 (2012).","journal-title":"Nat. Cell Biol."},{"key":"58996_CR29","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/1476-4598-9-154","volume":"9","author":"Q Zhao","year":"2010","unstructured":"Zhao, Q. et al. Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis. Mol. Cancer 9, 154\u2013154, https:\/\/doi.org\/10.1186\/1476-4598-9-154 (2010).","journal-title":"Mol. Cancer"},{"key":"58996_CR30","doi-asserted-by":"publisher","first-page":"4508","DOI":"10.1038\/onc.2013.399","volume":"33","author":"LS Fiore","year":"2014","unstructured":"Fiore, L. S. et al. c-Abl and Arg induce cathepsin-mediated lysosomal degradation of the NM23-H1 metastasis suppressor in invasive cancer. Oncogene 33, 4508\u20134520 (2014).","journal-title":"Oncogene"},{"key":"58996_CR31","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/bs.ctdb.2014.11.005","volume":"111","author":"KA Fantauzzo","year":"2015","unstructured":"Fantauzzo, K. A. & Soriano, P. Receptor tyrosine kinase signaling: regulating neural crest development one phosphate at a time. Curr. Top. Dev. Biol. 111, 135\u2013182, https:\/\/doi.org\/10.1016\/bs.ctdb.2014.11.005 (2015).","journal-title":"Curr. Top. Dev. Biol."},{"key":"58996_CR32","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/cancers3010126","volume":"3","author":"WE Damsky","year":"2010","unstructured":"Damsky, W. E., Rosenbaum, L. E. & Bosenberg, M. Decoding melanoma metastasis. Cancers 3, 126\u2013163, https:\/\/doi.org\/10.3390\/cancers3010126 (2010).","journal-title":"Cancers"},{"key":"58996_CR33","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/labinvest.2017.104","volume":"98","author":"I Khan","year":"2018","unstructured":"Khan, I. & Steeg, P. S. Metastasis suppressors: functional pathways. Lab. Invest. 98, 198\u2013210, https:\/\/doi.org\/10.1038\/labinvest.2017.104 (2018).","journal-title":"Lab. Invest."},{"key":"58996_CR34","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nrc2594","volume":"9","author":"SC Smith","year":"2009","unstructured":"Smith, S. C. & Theodorescu, D. Learning therapeutic lessons from metastasis suppressor proteins. Nat. Rev. Cancer 9, 253\u2013264, https:\/\/doi.org\/10.1038\/nrc2594 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"58996_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2774-3","volume":"16","author":"S S Franco","year":"2016","unstructured":"S Franco, S. et al. In vitro models of cancer stem cells and clinical applications. BMC Cancer 16, 738, https:\/\/doi.org\/10.1186\/s12885-016-2774-3 (2016).","journal-title":"BMC Cancer"},{"key":"58996_CR36","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.ccr.2010.10.012","volume":"18","author":"E Quintana","year":"2010","unstructured":"Quintana, E. et al. Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell 18, 510\u2013523, https:\/\/doi.org\/10.1016\/j.ccr.2010.10.012 (2010).","journal-title":"Cancer Cell"},{"key":"58996_CR37","doi-asserted-by":"publisher","first-page":"22960","DOI":"10.18632\/oncotarget.25160","volume":"9","author":"EE Bosco","year":"2018","unstructured":"Bosco, E. E. et al. Preclinical evaluation of a GFRA1 targeted antibody-drug conjugate in breast cancer. Oncotarget 9, 22960\u201322975, https:\/\/doi.org\/10.18632\/oncotarget.25160 (2018).","journal-title":"Oncotarget"},{"issue":"2","key":"58996_CR38","doi-asserted-by":"publisher","first-page":"a008326","DOI":"10.1101\/cshperspect.a008326","volume":"5","author":"S. Bhatt","year":"2013","unstructured":"Bhatt, S., Diaz, R. & Trainor, P. A. Signals and switches in Mammalian neural crest cell differentiation. Cold Spring Harb Perspect Biol 5, https:\/\/doi.org\/10.1101\/cshperspect.a008326 (2013).","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"58996_CR39","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1098\/rstb.2007.2252","volume":"363","author":"S Kuriyama","year":"2008","unstructured":"Kuriyama, S. & Mayor, R. Molecular analysis of neural crest migration. Philos. Trans. R. Soc. Lond. B Biol. Sci. 363, 1349\u20131362, https:\/\/doi.org\/10.1098\/rstb.2007.2252 (2008).","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"issue":"11","key":"58996_CR40","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.3390\/ijms19113491","volume":"19","author":"Toshimitsu Yamaoka","year":"2018","unstructured":"Yamaoka, T., Kusumoto, S., Ando, K., Ohba, M. & Ohmori, T. Receptor Tyrosine Kinase-Targeted Cancer Therapy. Int. J. Mol. Sci. 19, https:\/\/doi.org\/10.3390\/ijms19113491 (2018).","journal-title":"International Journal of Molecular Sciences"},{"key":"58996_CR41","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1248\/bpb.34.1774","volume":"34","author":"K Takeuchi","year":"2011","unstructured":"Takeuchi, K. & Ito, F. Receptor tyrosine kinases and targeted cancer therapeutics. Biol. Pharm. Bull. 34, 1774\u20131780, https:\/\/doi.org\/10.1248\/bpb.34.1774 (2011).","journal-title":"Biol. Pharm. Bull."},{"issue":"1","key":"58996_CR42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"Michael Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene ontology: tool for the unification of biology. Nat Genet. 25, 25\u201329, https:\/\/doi.org\/10.1038\/75556 (2000).","journal-title":"Nature Genetics"},{"key":"58996_CR43","doi-asserted-by":"publisher","unstructured":"The Gene Ontology Consortium. The Gene Ontology Resource: 20 years and still GOing strong. Nucleic Acids Res. 47, D330\u2013D338, https:\/\/doi.org\/10.1093\/nar\/gky1055 (2019).","DOI":"10.1093\/nar\/gky1055"},{"issue":"D1","key":"58996_CR44","doi-asserted-by":"publisher","first-page":"D183","DOI":"10.1093\/nar\/gkw1138","volume":"45","author":"Huaiyu Mi","year":"2016","unstructured":"Mi, H. et al. PANTHER version 11: expanded annotation data from Gene Ontology and Reactome pathways, and data analysis tool enhancements. Nucleic Acids Res. 45, D183\u2013D189, https:\/\/doi.org\/10.1093\/nar\/gkw1138 (2017).","journal-title":"Nucleic Acids Research"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58996-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58996-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58996-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T15:12:11Z","timestamp":1672672331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58996-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,6]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["58996"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-58996-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,6]]},"assertion":[{"value":"17 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1971"}}